SLC16A1 and prostate neoplasm: Metabolic symbiosis of CAFs with epithelial cancer cells has been identified in (monocarboxylate transporter 1) MCT1-positive prostate tumor cells and MCT4-positive CAFs (Pértega-Gomes et al., 2014).